University of Kentucky

UKnowledge
Maxwell H. Gluck Equine Research Center
Faculty Publications

Maxwell H. Gluck Equine Research Center

1-2016

In Vivo-Expressed Proteins of Virulent Leptospira interrogans
Serovar Autumnalis N2 Elicit Strong IgM Responses of Value in
Conclusive Diagnosis
Veerapandian Raja
Bharathidasan University, India

Santhanam Shanmughapriya
Bharathidasan University, India

Murugesan Kanagavel
Bharathidasan University, India

Sergey Artiushin
University of Kentucky

Sridhar Velineni
University of Kentucky, sridharvelineni@uky.edu
Follow this and additional works at: https://uknowledge.uky.edu/gerc_facpub
See next page for additional authors
Part of the Large or Food Animal and Equine Medicine Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Raja, Veerapandian; Shanmughapriya, Santhanam; Kanagavel, Murugesan; Artiushin, Sergey; Velineni,
Sridhar; Timoney, John F.; and Natarajaseenivasan, Kalimuthusamy, "In Vivo-Expressed Proteins of
Virulent Leptospira interrogans Serovar Autumnalis N2 Elicit Strong IgM Responses of Value in
Conclusive Diagnosis" (2016). Maxwell H. Gluck Equine Research Center Faculty Publications. 8.
https://uknowledge.uky.edu/gerc_facpub/8

This Article is brought to you for free and open access by the Maxwell H. Gluck Equine Research Center at
UKnowledge. It has been accepted for inclusion in Maxwell H. Gluck Equine Research Center Faculty Publications
by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar Autumnalis
N2 Elicit Strong IgM Responses of Value in Conclusive Diagnosis
Digital Object Identifier (DOI)
http://dx.doi.org/10.1128/CVI.00509-15

Notes/Citation Information
Published in Clinical and Vaccine Immunology, v. 23, no. 1, p. 65-72.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
The copyright holders have granted the permission for posting the article here.

Authors
Veerapandian Raja, Santhanam Shanmughapriya, Murugesan Kanagavel, Sergey Artiushin, Sridhar
Velineni, John F. Timoney, and Kalimuthusamy Natarajaseenivasan

This article is available at UKnowledge: https://uknowledge.uky.edu/gerc_facpub/8

crossmark

In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar
Autumnalis N2 Elicit Strong IgM Responses of Value in Conclusive
Diagnosis
Veerapandian Raja,a Santhanam Shanmughapriya,a* Murugesan Kanagavel,a Sergey C. Artiushin,b Sridhar Velineni,b
John F. Timoney,b Kalimuthusamy Natarajaseenivasana
Medical Microbiology Laboratory, Department of Microbiology, Centre of Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli, Indiaa; Gluck Equine
Research Center, University of Kentucky, Lexington, Kentucky, USAb

L

eptospirosis is a reemerging infectious disease of global importance, caused by pathogenic spirochetes of the genus Leptospira. Increased economic and recreational activity in pristine areas as well as flooding associated with climatic change has
increased human exposure to leptospires. Indeed, several large
outbreaks have been reported in Nicaragua (1, 2), Brazil (3), New
Caledonia (4), the Federated States of Micronesia (5), Japan (6),
and India (7–10) in recent years. Conventionally, culture positivity, seroconversion, or 4-fold rises in microscopic agglutination
test (MAT) titers are demonstrated for confirmation of leptospirosis. Per WHO recommendations, the standard reference
method for diagnosis of leptospirosis is MAT (11). Enzyme-linked
immunosorbent assay (ELISA) offers reasonable sensitivity and
the possibility of handling many samples at a time. ELISA has been
developed with a number of modifications (12).
Immune responses include antibodies to numerous leptospiral
proteins constitutively expressed or upregulated during infection
(13). Antibodies of the IgM isotype appear about 4 days after onset
of fever and headache and are responsible for clearance of leptospires from the bloodstream. Hypothetically, proteins specifically
induced during in vivo growth but not expressed by in vitro cultures have enhanced value because of their potential involvement
in pathogenesis and participation in acquired immune protective
responses (14). Examples of such proteins that have gained prominence as diagnostic reagents and vaccine candidates are LigA and
LigB immunoglobulin-like proteins and HbpA expressed strongly
in vivo and found only on freshly isolated pathogenic Leptospira
species (15–18). The diagnostic and vaccine efficacy of LigA protein and its immunogenic epitopes has been studied extensively
(15, 19–23). Thus, studies of proteins increased in abundance in
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vivo not only contribute to understanding of host-pathogen interactions but also are helpful in design of novel diagnostics and
vaccines.
In the present study, we have identified in vivo-expressed proteins of virulent Leptospira interrogans serovar Autumnalis strain
N2 through an expression gene library screening. The library was
screened with pooled patient sera, and IgM ELISA incorporating
the identified proteins was highly sensitive and specific for the
conclusive diagnosis of human leptospirosis.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Leptospira interrogans serovar
Autumnalis strain N2 was used for the genomic DNA isolation and library
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Leptospirosis is a serious zoonosis that is underdiagnosed because of limited access to laboratory facilities in Southeast
Asia, Central and South America, and Oceania. Timely diagnosis of locally distributed serovars of high virulence is crucial
for successful care and outbreak management. Using pooled patient sera, an expression gene library of a virulent Leptospira interrogans serovar Autumnalis strain N2 isolated in South India was screened. The identified genes were characterized, and the purified recombinant proteins were used as antigens in IgM enzyme-linked immunosorbent assay (ELISA)
either singly or in combination. Sera (n ⴝ 118) from cases of acute leptospirosis along with sera (n ⴝ 58) from healthy subjects were tested for reactivity with the identified proteins in an ELISA designed to detect specific IgM responses. We have
identified nine immunoreactive proteins, ArgC, RecA, GlpF, FliD, TrmD, RplS, RnhB, Lp28.6, and Lrr44.9, which were
found to be highly conserved among pathogenic leptospires. Apparently, the proteins ArgC, RecA, GlpF, FliD, TrmD, and
Lrr44.9 are expressed during natural infection of the host and undetectable in in vitro cultures. Among all the recombinant proteins used as antigens in IgM ELISA, ArgC had the highest sensitivity and specificity, 89.8% and 95.5%, respectively, for the conclusive diagnosis of leptospirosis. The use of ArgC and RecA in combination for IgM ELISA increased the
sensitivity and specificity to 95.7% and 94.9%, respectively. ArgC and RecA thus elicited specific IgM responses and were
therefore effective in laboratory confirmation of Leptospira infection.
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the antigen were administered 14 and 28 days after the primary immunization. Serum was obtained 35 days after the primary immunization (23).
The study protocol was approved by the Institutional Animal Ethics Committee (IAEC) of Bharathidasan University (BDU/IAEC/2011/29/29-032011).
Genomic DNA library construction and screening. A ZAPII library
containing 3- to 5-kb random fragments of L. interrogans serovar Autumnalis strain N2 was screened to identify phage that expressed gene products reactive with pooled patient sera (see Table S3 in the supplemental
material) as described elsewhere (24) with some modifications. The secondary antibody was horseradish peroxidase (HRP)-labeled antihuman
IgG (Sigma, St. Louis, MO) diluted 1:4,000. Secondary screening was performed with hyperimmune serum (HIS) raised in rabbit against heatextracted antigen to identify plaques reactive with patient sera but not
HIS. Negative clones that did not react with HIS were considered potential
producers of in vivo antigens.
DNA sequencing and expression of recombinant proteins. Suspected plaques on agar plugs were transferred to 500 l of SM buffer and
allowed to elute overnight. Plasmids containing the inserts were rescued
from selective reactive phages by using ExAssist helper phage and E. coli
SOLR according to the manufacturer’s instructions. Plasmid DNA was
isolated from reactive clones using a QIAprep spin miniprep kit (Qiagen,
Valencia, CA) and sequenced in a commercial sequencing facility (Macrogen, South Korea) using T3, T7, and custom-designed primers. Sequences were edited with Chromas 1.61 (Technelysium Pty. Ltd., Queensland, Australia) and aligned and connected with DNASIS (Hitachi
Software Engineering Co., Ltd., San Francisco, CA). DNA sequences thus
obtained were compared with the whole-genome sequences of L. interrogans serovar Lai strain 56601 and L. interrogans serovar Copenhageni
strain Fiocruz L1-130, and homologies were identified by a BLAST search
(http://www.ncbi.nlm.nih.gov/BLAST/).
Primer sequences used for the specific amplification of the identified
genes are given in Table S4 in the supplemental material. Following PCR
amplification (see Fig. S1A in the supplemental material), the amplicons
were cloned into predigested pET15b (Novagen, Madison, WI) (argC,
glfP, fliD, trmD, rplS, rnhB, lp28.6, and lrr44.9) or pRSETA (Invitrogen,
USA) (recA). Recombinant plasmids were transformed into E. coli
BL21(DE3) for pET15b and E. coli BL21(DE3)pLysS for pRSETA. The
presence of the correct inserts was confirmed by colony PCR, restriction
endonuclease analysis (REA), and DNA sequencing (see Fig. S1B in the
supplemental material).
Expression of His6 proteins was induced with 1 mM isopropyl-␤-Dthiogalactopyranoside (IPTG) when cultures reached an optical density at
600 nm (OD600) of 0.6, and cells were harvested after 2 to 3 h. Recombinant His-tagged proteins were isolated using Talon metal affinity resin
(Clontech Laboratories, Inc.) in buffer containing 8 M urea according to
the manufacturer’s recommendations. The purified recombinant proteins were dialyzed against 10 mM Tris (pH 7.5) containing 50 mM NaCl,
and their immunoreactivity was assessed by immunoblotting.
SDS-polyacrylamide gel electrophoresis and immunoblotting. Proteins were separated on 10% acrylamide gels by SDS-PAGE and transferred electrophoretically to a nitrocellulose membrane. After blocking,
membranes were incubated with pooled patient sera or rabbit HIS followed by incubation with anti-human or anti-rabbit IgG conjugated with
horseradish peroxidase (Sigma, St. Louis, MO). Membranes were developed and visualized using 4-chloro-1-naphthol (Sigma, St. Louis, MO).
Enzyme-linked immunosorbent assay. A checkerboard titration was
performed in 96-well flat-bottom polystyrene Microtest III assay plates
(Falcon; Becton, Dickinson, Oxnard, CA) with patient and control sera in
doubling dilutions and tested against 0.1 to 5.0 g/well of antigen to
determine the optimum concentration of the recombinant proteins in
diagnosis. Wells were coated with 0.2 g of recombinant proteins (optimized concentration in single) using carbonate buffer (pH 9.6) overnight
at 4°C followed by blocking with 4% nonfat dry milk. All sera were added
in a dilution of 1:200 in triplicate and incubated for 1 h at 37°C. Bound
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construction. The MAT was performed to evaluate serological evidence of
leptospiral infection (11). A panel of 12 reference strains was used which
included the following serogroups: Australis (serovar Australis, strain Ballico), Autumnalis (serovar Autumnalis, strain Akiyami A), Ballum (serovar Ballum, strain Mus 127), Bataviae (serovar Bataviae, strain Swart),
Canicola (serovar Canicola, strain Hond Utrecht IV), Icterohaemorrhagiae (serovar Icterohaemorrhagiae, strain RGA), Grippotyphosa
(serovar Grippotyphosa, strain Moskva V), Hebdomadis (serovar
Hebdomadis, strain Hebdomadis), Javanica (serovar Poi, strain Poi),
Pomona (serovar Pomona, strain Pomona), Sejroe (serovar Hardjo,
strain Hardjoprajitno), and Pyrogenes (serovar Pyrogenes, strain Salinem). The strains were obtained from the WHO Reference Centre for
Leptospirosis, Indian Council of Medical Research (ICMR), Regional
Medical Research Centre (RMRC), Port Blair, India, and maintained
by regular subculturing in Ellinghausen-McCullough-Johnson-Harris
(EMJH) bovine serum albumin-Tween 80 medium (Difco Laboratories, USA) at the Medical Microbiology Laboratory, Bharathidasan
University, Tiruchirappalli, India.
Escherichia coli SOLR and XL1-Blue MRF= (Stratagene, La Jolla, CA)
were hosts for phage manipulation and plasmid excision. E. coli NovaBlue,
BL21(DE3), and BL21(DE3)pLysS (Novagen, Madison, WI) were used
for cloning and expression of recombinant proteins and were routinely
grown in Luria-Bertani (LB) broth or on LB agar.
Study site, patients, case definition, and ethics. The samples for this
study were obtained through our routine hospital-based surveillance at
Annal Mahatma Gandhi Memorial General Hospital, Tiruchirappalli,
Tamilnadu, India. Tiruchirappalli is a municipal corporation of urban
agglomeration surrounded by villages actively involved in agriculture (especially cultivation of rice, sugarcane, and groundnut) and cattle rearing.
In Tiruchirappalli, the temperature ranges from 28°C to 38°C, and the
geographical position of this area is 10.81°N latitude and 78.69°E longitude.
In total, 118 serum samples (see Table S1 in the supplemental material) with a MAT titer of ⱖ1:160 were selected from a bank of 754 laboratory-confirmed samples (a positive IgM ELISA, isolation of leptospires
from the blood, seroconversion, or 4-fold rise in titer by MAT) collected
during the early phase of illness (0 to 10 days after the onset of disease).
The age and sex distributions of the confirmed cases included in the study
are given in Table S2 in the supplemental material. A total of 58 seronegative healthy controls selected from a group of cases matched with respect
to age (⫾5 years) and sex and 98 patients who were hospitalized with a
clinical suspicion of leptospirosis and subsequently diagnosed as having
other illness based on laboratory evidence (MAT and ELISA negative for
leptospirosis) were also included to study the efficiency of the ELISA developed in the present study. Informed written consent was obtained from
both cases and controls before sampling, and the study protocol was approved by the Institutional Ethics Committee (IEC) of Bharathidasan
University (DM/2007/101/373/Project No.2) as well as permitted by the
Directorate of Health Services (reference no. 5796/TV 1/07), Tamilnadu.
The obtained sera were stored at ⫺80°C until use.
Preparation of heat-extracted antigen. Leptospiral heat-extracted
antigen was prepared from 7-day-old leptospiral culture (1 ⫻ 108 to 2 ⫻
108/ml) of L. interrogans serovar Autumnalis. The culture was killed by
formalin (final concentration, 0.5% [vol/vol]), heated in a boiling water bath for 30 min, and centrifuged for 30 min at 10,000 ⫻ g. The
supernatant was used as heat-extracted antigen. Protein concentrations were determined by the bicinchoninic acid (BCA) method
(Sigma, St. Louis, MO).
Polyclonal antisera. Polyclonal antisera were raised in New Zealand
White rabbits by subcutaneous administration of 1 l of N-acetylmuramyl-L-alanyl-D-isoglutamine (Sigma, St. Louis, MO) and 100 g of
heat-extracted antigen prepared from laboratory-grown L. interrogans serovar Autumnalis strain N2 or purified recombinant proteins adsorbed to
aluminum hydroxide (Alhydrogel; Accurate Chemical & Scientific Corp.,
Westbury, NY). Booster injections containing 100 g (subcutaneous) of
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TABLE 1 Conservation of identified proteins among different species of Leptospira
Identity (%)a
Molecular
GenBank
Protein accession no. L. interrogans L. borgpetersenii L. kirschneri L. weilii L. noguchii L. alexanderi L. santarosai L. kmetyi L. biflexa mass (kDa)
ArgC
RecA
GlpF
FliD
TrmD
RplS
RnhB
Lp28.6
Lrr44.9

AGW25359
AGW25358
AGW25365
AGW25366
AGW25364
AGW25363
AGW25362
AGW25361
AGW25360

98
99
99
99
99
99
99
99
100

84
95
87
87
91
90
81
63
93

97
99
97
98
98
96
92
94
98

83
95
85
94
91
92
83
69
93

92
99
96
96
96
96
92
87
98

83
95
85
89
90
87
82
65
93

84
96
88
87
NA
88
92
93
94

84
95
91
92
90
93
81
66
91

59
78
67
53
60
68
41
NA
44

37.8
39
25.4
69.9
25.6
15.5
26.5
28.6
44.96

a

IgM was detected using peroxidase-conjugated anti-human IgM (Sigma),
followed by development using 0.08% (wt/vol) 5-aminosalicylic acid. Optical densities (ODs) were read at 490 nm. For combination ELISA, checkerboard titration was carried out to determine the best working concentration of the recombinant proteins in combination. Combinations were
made by mixing ArgC (0.2 g) and RecA (0.1 g) (combo 1); GlpF (0.1
g) and FliD (0.2 g) (combo 2); and TrmD (0.1 g), RplS (0.1 g),
RnhB (0.2 g), Lp28.6 (0.1 g), and Lrr44.9 (0.1 g) (combo 3).
Statistical analysis. Data were analyzed using version 6.0 of the Statistica software package (StatSoft, Tulsa, OK). Cutoff values for each recombinant antigen ELISA were defined as the corresponding mean plus 2
standard deviations (SD) from the sera of healthy controls. Sensitivity was
defined as the percentage of the laboratory-confirmed cases of leptospirosis whose serum samples gave mean ODs greater than the relevant cutoff value. Specificity was calculated as the percentage of the control individuals whose samples gave mean ODs below the relevant cutoff value.
The positive and negative predictive values (PPV and NPV, respectively)
are the proportions of true positives and true negatives, respectively. The
percent agreement between the results of the recombinant protein-based
ELISA and the results of the MAT, and the corresponding kappa coefficients, were determined using Epi Info version 6.0 (Centers for Disease
Control and Prevention, Atlanta, GA). The LigA-C peptides identified in
our previous study (23) were used as positive controls in ELISA in order to
compare the diagnosis efficacy of the newly identified proteins with that of
a well-defined in vivo-expressed protein.
Nucleotide sequence accession numbers. The sequences obtained
were submitted to GenBank with the accession numbers KF240786,
KF240787, KF240788, KF240789, KF270743, KF270744, KF270745,
KF270746, and KF270747 for recA, argC, lrr44.9, lp28.6, rnhB, rplS, trmD,
glpF, and fliD, respectively.

RESULTS

Prevalence of leptospirosis among samples. Among the 118
cases included in the study, circulating antileptospiral antibodies were detected by MAT and titers were reported to be in the
range between 1:160 and 1:1,280. The most frequently observed circulating serovar was Autumnalis (25.4%), followed
by Australis (17.8%) and Canicola (15.3%) (see Table S5 in the
supplemental material). Of the 118, 7 cases were found to be
culture positive, with 4 isolates identified as serovar Canicola
and 3 as Autumnalis.
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Identification of immunoreactive proteins by DNA library
screening. Screening of approximately 105 plaques of the lambda
library revealed 18 reactive plaques, and final screening identified
highly expressive immunoreactive clones N2 ⫹  4-3 III, N2 ⫹ 
16-1 III, and N2 ⫹  17-3 III. Sequences of plasmids rescued from
the selected lambda phages were compared with genome sequences of L. interrogans serovar Lai strain 56601 and serovar
Copenhageni strain Fiocruz L1-130. Sequence analysis confirmed
two open reading frames in clone N2 ⫹  4-3 III (argC and recA),
two in N2 ⫹  16-1 III (glpF and fliD), and five in N2 ⫹  17-3 III
(trmD, rplS, rnhB, lp28.6, and lrr44.9). The conservation of the
proteins among various leptospiral species was determined by
multiple-sequence alignment. The corresponding protein sequences (as given in Table 1) were retrieved from GenBank and
analyzed with the BioEdit sequence alignment editor (version
7.1.3.0). The proteins were found to be highly conserved (⬃80 to
100% sequence identity) among pathogenic leptospires but
shared ⬃23 to 78% identity with their counterparts in nonpathogenic Leptospira biflexa and other pathogenic bacteria (Table 1; see
also Table S6 in the supplemental material).
Production of recombinant proteins and their immunoreactivity. The purity of complete His6 tag fusion proteins expressed in either E. coli BL21(DE3) or E. coli BL21(DE3)pLysS
was confirmed by SDS-PAGE and Coomassie brilliant blue
staining (see Fig. S2 in the supplemental material). The determined molecular masses of the purified proteins were consistent with those predicted from their amino acid compositions
(Table 1). The purified proteins were immunoblotted with
pooled patient sera, and the immunoreactivity of the purified
proteins was assessed (Fig. 1A).
In vivo expression of the identified proteins during natural
infection. Western blotting assays of the purified proteins developed with HIS (against laboratory culture N2) did not reveal reactivity of the identified proteins except for RplS, RnhB, and
Lp28.6 (Fig. 1B). This made us hypothesize that the newly identified and characterized proteins ArgC, RecA, FliD, TrmD, and
Lrr44.9 could possibly be expressed during natural infection of the
host and not in vitro.
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L. interrogans, YP_001698, WP_017861766, WP_000535417.1, NP_713634.1, NP_712569.1, NP_712568.1, NP_712567.2, WP_000778152.1, NP_712564.1; L. borgpetersenii,
WP_002761303, WP_002761315, WP_002752499.1, WP_002752524.1, WP_004280339.1, YP_798039.1, YP_798038.1, WP_002751302.1, WP_002751417.1; L. kirschneri,
WP_004779134, WP_004752583, WP_025183617.1, WP_004781580.1, WP_004760731.1, WP_004780226.1, WP_004780231.1, WP_020779461.1, WP_004751784.1; L. weilii,
WP_004504782, WP_002996988, WP_004506831.1, WP_003010986.1, WP_004507221.1, WP_002996170.1, WP_002995931.1, WP_002996364.1, WP_002996221.1; L. noguchii,
WP_004454314, WP_004424072, WP_004426432, WP_004426445.1, WP_004430719.1, WP_004453264.1, WP_004423647.1, WP_004430727.1, WP_004424196.1; L. alexanderi,
WP_010578142, WP_010578143, WP_020985028.1, WP_010576705.1, WP_010579003.1, WP_010579002.1, WP_010579001.1, WP_010579000.1, WP_010578998.1; L. santarosai,
WP_016754218, WP_004468644, WP_016755555.1, WP_004494481.1, WP_004487102.1, WP_020767000.1, WP_020766986.1, WP_004470165.1; L. kmetyi, WP_020985623,
WP_010574861, WP_010573697.1, WP_020985940.1, WP_010574774.1, WP_010574773.1, WP_010574772.1, WP_010574771.1, WP_010574769.1; L. biflexa, YP_001962522,
AAC43586, WP_012387177.1, YP_001837994.1, YP_001839046.1, YP_001839047.1, YP_001962701.1, YP_001839051.1. NA, not available.

Raja et al.

To further prove the proteins ArgC and RecA to be expressed in vivo, L. interrogans serovar Autumnalis strain N2MACS (mouse-adapted challenge strain) was selected from its
parent strain N2 (laboratory strain), by passaging the isolate in
BALB/c mice (cyclophosphamide treated) for ⬃15 times. L. interrogans strain N2-MACS was passaged in vitro (N2-MACS1, -2,
-3, and -4) four times. Heat-extracted antigens were prepared
from N2-MACS, N2-MACS1, N2-MACS2, N2-MACS3, N2MACS4, and N2 and immunoblotted with hyperimmune rabbit sera for ArgC/RecA/LipL32. The levels of ArgC and RecA
expression were significantly higher in N2-MACS and decreased as the isolates were passaged in vitro. No differential
expression was observed for LipL32 (Fig. 2).
Further to confirm that ArgC and RecA are not temperature

FIG 2 ArgC and RecA are proteins expressed only during natural infection in vivo. Heat-extracted proteins from L. interrogans serovar Autumnalis strains
N2-MACS (lanes 1), N2-MACS1 (lanes 2), N2-MACS2 (lanes 3), N2-MACS3 (lanes 4), N2-MACS4 (lanes 5), and N2 (lanes 6) were immunoblotted with
hyperimmune rabbit sera for ArgC (A), RecA (B), and LipL32 (C). The levels of ArgC and RecA expression were significantly higher in N2-MACS and decreased
as the isolates were passaged in vitro. No differential expression was observed for LipL32.
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FIG 1 Immunoreactivity of the purified proteins to patient sera or hyperimmune rabbit serum raised against laboratory-grown N2 strain. (A) Western
blot (WB) of the purified proteins probed with pooled patient sera. Purified
proteins: ArgC (37.8 kDa), RecA (39 kDa), GlpF (25.4 kDa), FliD (69.9 kDa),
TrmD (25.6 kDa), RplS (15.5 kDa), RnhB (26.5 kDa), Lp28.6 (28.6 kDa), and
Lrr44.9 (44.9 kDa). (B) Western blot of the purified proteins probed with
rabbit HIS. Purified proteins: ArgC (37.8 kDa), RecA (39 kDa), GlpF (25.4
kDa), FliD (69.9 kDa), TrmD (25.6 kDa), RplS (15.5 kDa), RnhB (26.5 kDa),
Lp28.6 (28.6 kDa), and Lrr44.9 (44.9 kDa).

regulated, heat-extracted proteins of L. interrogans serovar Autumnalis strain N2 grown at 30, 37, and 42°C were immunoblotted with ArgC/RecA-specific polyclonal rabbit serum. The immunoblots did not show any detectable level of ArgC/RecA (Fig. 3;
see also Fig. S3 in the supplemental material). In contrast, LipL32
was expressed by laboratory-grown cultures at different temperatures. LigA-C was used as a positive control. This confirms that
ArgC and RecA are expressed in vivo and are not temperature
regulated.
Evaluation of the recombinant proteins in serological diagnosis. The optimum antigen concentration of the recombinant
protein to be utilized in IgM ELISA for serological diagnosis as
determined by checkerboard assay was 0.2 g/well. The mean
plus 2 SD of the absorbance values from healthy individuals
was defined as the cutoff value to achieve diagnostic specificity.
The cutoff values for the recombinant proteins were in the
range between 0.101 and 0.186 (Fig. 4A to I). ELISA with purified recombinant proteins demonstrated a sensitivity in the
range between 44.9 and 92.3% and a specificity between 46.9
and 96.9%. Among all the recombinant proteins analyzed,
ArgC had the highest sensitivity and specificity for the diagnosis of leptospirosis (Table 2). A positive correlation was demonstrated between MAT titer and ELISA OD values (see Fig. S4
in the supplemental material). Then, we asked whether the
combination of recombinant proteins in ELISA format could
increase the sensitivity and specificity of the test. To test that,
we used three different combinations based on the immunoreactive clones obtained (N2 ⫹  4-3 III, N2 ⫹  16-1 III, and
N2 ⫹  17-3 III): combo 1 (ArgC and RecA), combo 2 (GlpF
and FliD), and combo 3 (TrmD, RplS, RnhB, Lp28.6, and
Lrr44.9). The purified recombinant proteins were mixed per the
proportions mentioned above and used in ELISA. As expected, the
combination of recombinant proteins increased the sensitivity.

In Vivo Proteins for Diagnosis of Leptospirosis

Combo 1 had a sensitivity of 95.7% and a specificity of 94.9%
(Table 2). The sensitivity of combo 1 ELISA was ⬃5 to 10% greater
than that of the ELISA using ArgC or RecA separately, and it was
comparable to the sensitivity and specificity (Table 2; see also Fig.
S5 in the supplemental material) of LigA-C peptides identified in
our previous study (23).
DISCUSSION

Leptospira interrogans has caused serious fatal illness worldwide.
The early clinical presentation of fever, headache, and myalgia
may be difficult to distinguish from febrile illness associated
with diseases such as dengue, viral hemorrhagic infections, and
rickettsiosis. Thus, an objective test that promptly detects the
causative Leptospira, its DNA, or a specific antibody would be
extremely valuable in guiding treatment and providing awareness of outbreaks, thereby facilitating provisional diagnosis of
patients with clinical presentations/histories. In the present
study, the use of purified recombinant ArgC and RecA in combination proved to be an effective antigen to provide conclusive
diagnosis of leptospirosis. Percent sensitivity and specificity
were ⬎90% based on comparisons with sera of healthy individuals and of patients with other febrile infectious diseases.
Humoral immune responses to pathogenic bacteria are mainly
directed at surface-exposed and secreted antigens accessible to
antibody in plasma and mucosal secretions. Thus, a screen of an
expression gene library with immune serum identifies a disproportionately large number of proteins with sequences predictive
of surface exposure (25–27). A consequence of this approach has
been failure to consider cytoplasmic proteins. The proteins ArgC
and RecA used as effective antigens are cytoplasmic proteins of L.
interrogans that participate in host immune responses. Neither of
these proteins was identified in a recent high-density protein microarray of serovar Copenhageni for which the selection criteria
included potential biological importance and antigenic features
(13).
The majority of studies of putative virulence factors impor-
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tant in microbial pathogenesis have focused on nonmetabolic
gene products. This is due, in part, to the belief that housekeeping and other genes common to pathogens and nonpathogens
are unimportant for pathogenesis. In fact, during the crucial
early phase of microbial proliferation in vivo, the ability of the
pathogen to synthesize or acquire scarce/unavailable nutrients
becomes critical. For example, iron acquisition factors are well
accepted as important for leptospiral pathogenesis (17, 18).
Acquisition or synthesis of other nutritional factors is less well
appreciated but supported by a variety of reports (28–30). The
frequent identification of biosynthesis genes following library
screening of random gene fusions or randomly generated
transposon mutants argues for their importance in pathogenesis (28, 29, 31).
The findings to date suggest that decreased levels of arginine
in human urine induce argC. Disruption of the carAB gene
involved with arginine and pyrimidine biosynthesis significantly reduced the ability of Salmonella to cause systemic infection (29). These studies also showed that in vivo arginine biosynthesis is required for optimal renal infection but not for optimal
infection of bladder and urine. RecA is a ubiquitous bacterial recombination protein essential both for DNA transformation (32,
33) and for mediation of bacterial SOS responses (34). Colonization and infection of host organs are potentially stressful for invading pathogens because they include the effects of antibacterial
factors such as pH, elevated temperature, osmolarity, and factors
released by other microorganisms on the mucosal surface. Some
stresses result in DNA damage, the repair of which involves RecA,
an enzyme critical for pairing of single-strand DNA with complementary regions of double-stranded DNA. Single-strand DNARecA produced following DNA injury activates self-catalysis of
LexA protein responsible for blocking expression of SOS genes for
proteins that repair DNA. Thus, RecA also functions as a LexA
coprotease. A significant decrease in intracellular pH has been
shown to result both in DNA damage via depurination in Salmonella enterica serovar Typhimurium and in induction of the DNA
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FIG 3 ArgC and RecA expression levels are not temperature regulated. Whole-cell lysate of L. interrogans serovar Autumnalis strain N2 grown at 30°C (lanes 1),
37°C (lanes 2), and 42°C (lanes 3) and purified recombinant protein (lanes 4), immunoblotted with hyperimmune rabbit sera for ArgC (A), RecA (B), LigA-C
(C), and LipL32 (D).

Raja et al.

on the y axis. IgM responses to purified recombinant proteins (A to I) are shown. Study groups: group 1, laboratory-confirmed cases of leptospirosis; group 2,
confirmed for other infectious diseases; group 3, seronegative healthy controls. The dashed lines represent the cutoff values for each antigen with the absolute
cutoff values on the right.

repair protein PolA (35). RecA may enhance resistance to oxidative killing by phagocytes based on evidence that a ⌬recA mutant
of Salmonella Typhimurium is sensitive to the killing effect of the
oxidative burst of macrophages (36). Furthermore, recA mutation
diminishes adherence to and colonization of rabbit intestine by
Vibrio cholerae (37). Infection by serovar Autumnalis and other
Leptospira serovars is clearly associated with consistent expression
of this immunogenic protein in the early stages of invasion/bacteremia, raising the possibility that it has a role in pathogenesis in
addition to that of DNA repair.
The identified in vivo-expressed proteins would have been involved in infection and stress responses of L. interrogans and thus
are upregulated during infection and elicited specific IgM responses in patients during the acute phase. Further studies focusing on the importance of the identified proteins will help determine whether these proteins represent site-specific or more global
virulence factors.

TABLE 2 Sensitivity, specificity, positive predictive value, and negative
predictive value for IgM ELISA using identified proteins separately and
in combination
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Sensitivity
(%)

Specificity
(%)

PPV
(%)

NPV
(%)
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86.4
71.1
74.5
82.2
44.9
92.3
88.9
83.9
95.7
96.6
93.2

96.9
89.8
65.3
78.5
86.7
46.9
81.6
85.7
87.7
94.9
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82
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94.8
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FIG 4 Evaluation of purified recombinant antigens in IgM ELISAs. Study groups are indicated on the x axis, and the optical density (OD) at 490 nm is indicated
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